Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Martine J Piccart-GebhartPatrick Therasse

Abstract

Taxanes (paclitaxel or docetaxel) have been sequenced or combined with anthracyclines (doxorubicin or epirubicin) for the first-line treatment of advanced breast cancer. This meta-analysis uses data from all relevant trials to detect any advantages of taxanes in terms of tumor response, progression-free survival (PFS), and survival. Individual patient data were collected on eight randomized combination trials comparing anthracyclines + taxanes (+ cyclophosphamide in one trial) with anthracyclines + cyclophosphamide (+ fluorouracil in four trials), and on three single-agent trials comparing taxanes with anthracyclines. Combination trials included 3,034 patients; single-agent trials included 919 patients. Median follow-up of living patients was 43 months, median survival was 19.3 months, and median PFS was 7.1 months. In single-agent trials, response rates were similar in the taxanes (38%) and in the anthracyclines (33%) arms (P = .08). The hazard ratios for taxanes compared with anthracyclines were 1.19 (95% CI, 1.04 to 1.36; P = .011) for PFS and 1.01 (95% CI, 0.88 to 1.16; P = .90) for survival. In combination trials, response rates were 57% (10% complete) in taxane-based combinations and 46% (6% complete) in control arms (P <...Continue Reading

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S ChanUNKNOWN 303 Study Group
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J JassemUNKNOWN Central & Eastern Europe and Israel Pacitaxel Breast Cancer Study Group
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George W SledgeWilliam C Wood
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Marc NabholtzUNKNOWN TAX 306 Study Group
Jul 30, 2005·British Journal of Cancer·D GhersiR J Simes
Feb 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hüseyin AbaliSercan Aksoy
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tomasz BurzykowskiPatrick Therasse

❮ Previous
Next ❯

Citations

Nov 19, 2011·Journal of Cancer Research and Clinical Oncology·Maurizio BelfiglioUNKNOWN Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)
Jul 14, 2009·Breast Cancer Research and Treatment·Eric M BalzerStuart S Martin
Feb 22, 2012·Current Treatment Options in Oncology·Ana Elisa Lohmann, Stephen Chia
Sep 24, 2010·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Gerald M Higa
Jan 1, 1990·Journal of Pharmaceutical and Biomedical Analysis·L CampanellaG Visco
Jan 21, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P J Barrett-LeeM W Verrill
Jul 18, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BeslijaUNKNOWN Central European Cooperative Oncology Group (CECOG)
Jan 22, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-U BlohmerS Kuemmel
Mar 26, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A ChanX Pivot
Dec 11, 2008·Journal of the National Cancer Institute·Philippe L Bedard, Martine J Piccart-Gebhart
Mar 12, 2010·Journal of the National Cancer Institute·Olivia PaganiUNKNOWN ESO-MBC Task Force
Jun 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A SparanoPierfranco Conte
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharon H GiordanoJames S Goodwin
Jun 26, 2010·The Oncologist·Filippo MontemurroMassimo Aglietta
Jul 28, 2011·OncoTargets and Therapy·Yutaka YamamotoHirotaka Iwase
Jun 16, 2009·Current Oncology·K M KingS Rix
Sep 23, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoE Winer
Sep 18, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·André F MoreiraIlídio J Correia
Aug 21, 2009·Journal of Cancer Research and Clinical Oncology·Cheng JinKefeng Dou
Dec 15, 2010·Expert Opinion on Investigational Drugs·Branislav Bystricky, Ian Chau
Aug 27, 2010·Expert Opinion on Drug Delivery·Bin WangMohammad F Kiani
May 8, 2010·Expert Opinion on Pharmacotherapy·Fausto PetrelliSandro Barni
Nov 3, 2012·Critical Reviews in Oncology/hematology·G von MinckwitzA Awada
Jun 5, 2012·Cancer Treatment Reviews·Birgit E P J VriensVivianne C G Tjan-Heijnen
Mar 20, 2012·The Breast : Official Journal of the European Society of Mastology·F CardosoE Winer
Oct 6, 2010·Advances in Surgery·Georgia M Beasley, John A Olson
Jan 26, 2010·Critical Reviews in Oncology/hematology·Claudia AndreettaFabio Puglisi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Kathy S AlbainJoyce O'Shaughnessy
© 2022 Meta ULC. All rights reserved